Literature DB >> 21050834

An increased risk of differentiated thyroid carcinoma in Iran with the 677C→T homozygous polymorphism in the MTHFR Gene.

Pezhman Fard-Esfahani1, Armaghan Fard-Esfahani, Parinaz Saidi, Shima Fayaz, Reyhaneh Mohabati, Mina Majdi.   

Abstract

BACKGROUND: Methylenetetrahydrofolate reductase (MTHFR) involves in folic acid metabolism which influences DNA methylation. A single nucleotide polymorphism (SNP) called 677C→T in MTHFR gene causes producing a thermolabile enzyme with reducing function and eventually defects DNA methylation. To determine association between germ-line polymorphism in MTHFR gene with differentiated thyroid carcinoma (DTC), this preliminary study was designed.
METHODS: This was a case-control study of 154 DTC patients and 198 cancer free individuals. Genotyping was performed by a multiplex PCR method and the frequencies of the 677C→T SNP in cases and controls were compared. The risk estimation was done by multivariate logistic regression analysis.
RESULTS: Compared to CC genotype, an increased risk of DTC for the 677C→T homozygous genotype was demonstrated (odds ratio [OR]: 2.08, 95% confidence interval [CI]: 0.82-5.25). Also, multivariate analysis demonstrated an increased risk of DTC in recessive fashion (TT vs. CC or CT) (OR: 2.38, 95% CI: 0.97-5.82).
CONCLUSION: The MTHFR 677C→T homozygous variant allele may be associated with increased risk of DTC.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21050834     DOI: 10.1016/j.canep.2010.10.001

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  8 in total

Review 1.  A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk.

Authors:  Muzeyyen Izmirli
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

Review 2.  Genetics and epigenetics of sporadic thyroid cancer.

Authors:  Dang Vu-Phan; Ronald J Koenig
Journal:  Mol Cell Endocrinol       Date:  2013-08-08       Impact factor: 4.102

3.  Polymorphisms of methylenetetrahydrofolate reductase and glutathione S-transferase are not associated with the risk of papillary thyroid cancer in Korean population.

Authors:  Sun-Seog Kweon; Min-Ho Shin; Hee-Nam Kim; Soo-Hyun Kim; Ho-Cheol Kang
Journal:  Mol Biol Rep       Date:  2014-02-18       Impact factor: 2.316

4.  Impact of methylenetetrahydrofolate reductase C677T polymorphism on the risk of gastric cancer and its interaction with Helicobacter pylori infection.

Authors:  Samaneh Saberi; Kazem Zendehdel; Sahar Jahangiri; Yeganeh Talebkhan; Afshin Abdirad; Nazanin Mohajerani; Maryam Bababeik; Najmeh Karami; Maryam Esmaili; Akbar Oghalaie; Parisa Hassanpour; Neda Amini; Mohammad Ali Mohagheghi; Mahmoud Eshagh Hossieni; Marjan Mohammadi
Journal:  Iran Biomed J       Date:  2012

Review 5.  MTHFR C677T gene polymorphism and head and neck cancer risk: a meta-analysis based on 23 publications.

Authors:  Yu-Ming Niu; Mo-Hong Deng; Wen Chen; Xian-Tao Zeng; Jie Luo
Journal:  Dis Markers       Date:  2015-01-31       Impact factor: 3.434

6.  MTHFR C677T polymorphism interaction with heavy alcohol consumption increases head and neck carcinoma risk.

Authors:  Xianlu Zhuo; Jue Song; Dairong Li; Yongzhong Wu; Qi Zhou
Journal:  Sci Rep       Date:  2015-06-02       Impact factor: 4.379

7.  Polymorphisms in MTHFR, MTR, RFC1 and CßS genes involved in folate metabolism and thyroid cancer: a case-control study.

Authors:  Tairine Zara-Lopes; Ana Lívia Silva Galbiatti-Dias; Márcia M Urbanin Castanhole-Nunes; João Armando Padovani-Júnior; José Victor Maniglia; Erika Cristina Pavarino; Eny Maria Goloni-Bertollo
Journal:  Arch Med Sci       Date:  2019-02-05       Impact factor: 3.318

8.  Association between MTHFR C677T polymorphism and thyroid cancer risk: a meta-analysis.

Authors:  Yulan Yan; Feng Han; Huo Fu; Weiyi Xia; Xi Qin
Journal:  Tumour Biol       Date:  2014-05-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.